Micah MackinsonCEO at VICO TherapeuticsSpeaker
Agenda Sessions
Targeting Expanded CAG Repeats Using ASO Therapy In Huntington's Disease And Wider Polygultamine Diseases
, 2:40pmView Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Targeting Expanded CAG Repeats Using ASO Therapy In Huntington's Disease And Wider Polygultamine Diseases